GUY JL[au] - Search Results

Year	Number of Results
1961	1
1964	1
1978	1
1991	1
2002	1
2003	3
2004	1
2005	2
2006	1
2008	2
2009	1
2018	2
2021	1
2022	0

1

Transcription Factor-Binding Site Identification and Enrichment Analysis.

Guy JL, Mor GG. Guy JL, et al. Methods Mol Biol. 2021;2255:241-261. doi: 10.1007/978-1-0716-1162-3_20. Methods Mol Biol. 2021. PMID: 34033108

2

Monitor for strictures after radiofrequency ablation.

Guy JL. Guy JL. Nursing. 2018 Aug;48(8):8. doi: 10.1097/01.NURSE.0000541400.13094.ad. Nursing. 2018. PMID: 30045230 No abstract available.

3

Membrane-associated zinc peptidase families: comparing ACE and ACE2.

Guy JL, Lambert DW, Warner FJ, Hooper NM, Turner AJ. Guy JL, et al. Biochim Biophys Acta. 2005 Aug 1;1751(1):2-8. doi: 10.1016/j.bbapap.2004.10.010. Epub 2004 Nov 6. Biochim Biophys Acta. 2005. PMID: 16054014 Free PMC article. Review.

4

ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors.

Turner AJ, Tipnis SR, Guy JL, Rice G, Hooper NM. Turner AJ, et al. Among authors: guy jl. Can J Physiol Pharmacol. 2002 Apr;80(4):346-53. doi: 10.1139/y02-021. Can J Physiol Pharmacol. 2002. PMID: 12025971 Review.

5

Evaluation of TAK-264, an Antibody-Drug Conjugate in Pancreatic Cancer Cell Lines and Patient-Derived Xenograft Models.

Schreiber AR, Nguyen A, Bagby SM, Arcaroli JJ, Yacob BW, Quackenbush K, Guy JL, Crowell T, Stringer B, Danaee H, Kalebic T, Messersmith WA, Pitts TM. Schreiber AR, et al. Among authors: guy jl. Clin Cancer Drugs. 2018;5(1):42-49. doi: 10.2174/2212697X05666180516120907. Clin Cancer Drugs. 2018. PMID: 30631747 Free PMC article.

6

Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts.

Guy JL, Lambert DW, Turner AJ, Porter KE. Guy JL, et al. Exp Physiol. 2008 May;93(5):579-88. doi: 10.1113/expphysiol.2007.040139. Epub 2008 Jan 25. Exp Physiol. 2008. PMID: 18223028 Free article.

7

Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.

Rella M, Rushworth CA, Guy JL, Turner AJ, Langer T, Jackson RM. Rella M, et al. Among authors: guy jl. J Chem Inf Model. 2006 Mar-Apr;46(2):708-16. doi: 10.1021/ci0503614. J Chem Inf Model. 2006. PMID: 16563001

8

Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis.

Guy JL, Jackson RM, Jensen HA, Hooper NM, Turner AJ. Guy JL, et al. FEBS J. 2005 Jul;272(14):3512-20. doi: 10.1111/j.1742-4658.2005.04756.x. FEBS J. 2005. PMID: 16008552 Free PMC article.

9

Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis.

Rushworth CA, Guy JL, Turner AJ. Rushworth CA, et al. Among authors: guy jl. FEBS J. 2008 Dec;275(23):6033-42. doi: 10.1111/j.1742-4658.2008.06733.x. FEBS J. 2008. PMID: 19021774 Free PMC article.

10

Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.

Guy JL, Jackson RM, Acharya KR, Sturrock ED, Hooper NM, Turner AJ. Guy JL, et al. Biochemistry. 2003 Nov 18;42(45):13185-92. doi: 10.1021/bi035268s. Biochemistry. 2003. PMID: 14609329

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results